| FEN1 — Flap Endonuclease 1 | |
|---|---|
| Symbol | FEN1 |
| Full Name | Flap Endonuclease 1 |
| Chromosome | 19q13.3 |
| NCBI Gene | 2237 |
| Ensembl | ENSG00000163945 |
| OMIM | 600406 |
| UniProt | P39748 |
| Diseases | [Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), Werner Syndrome |
| Expression | [Hippocampus](/brain-regions/hippocampus), Cerebral [cortex](/brain-regions/cortex), Cerebellum, Substantia nigra |
| Key Mutations | |
FEN1 (Flap Endonuclease 1) is a gene located on chromosome 19q13.3 that encodes a structure-specific nuclease essential for DNA replication and repair. The protein plays critical roles in DNA base excision repair (BER), long-patch BER (LP-BER), and Okazaki fragment maturation. Recent research has revealed that FEN1 dysfunction contributes significantly to neurodegenerative diseases including Alzheimer's Disease (AD) and Parkinson's Disease (PD), as impaired DNA repair accumulates in post-mitotic neurons leading to genomic instability, mitochondrial dysfunction, and neuronal death 1.
The gene is catalogued as NCBI Gene ID 2237, Ensembl ID ENSG00000163945, and OMIM 600406. The UniProt entry is P39748.
FEN1 is a member of the RAD2 nuclease family and possesses multiple enzymatic activities essential for DNA metabolism:
The protein functions as a homodimer and requires Mg²⁺ as a cofactor for catalysis. FEN1 recognizes specific DNA structures through its DNA binding domain and coordinates cleavage at the flap-base junction 2.
FEN1 is central to two critical DNA repair pathways:
1. Long-Patch Base Excision Repair (LP-BER)
During LP-BER, a damaged base is removed by a glycosylase, leaving an abasic site that is cleaved by AP endonuclease. DNA polymerase δ/ε then synthesizes 2-6 nucleotides, creating a flap structure that FEN1 cleaves. This pathway is particularly important for removing oxidized, alkylated, or abasic sites that are common forms of oxidative DNA damage in neurons 3.
2. Okazaki Fragment Processing
During lagging strand DNA synthesis, FEN1 processes Okazaki fragments by removing RNA primers and resolving flap structures. This ensures proper DNA replication and prevents replication stress that can lead to genomic instability.
FEN1 is expressed in multiple brain regions with high metabolic activity and oxidative stress exposure:
Expression data is available from the Allen Human Brain Atlas.
FEN1 plays a multifaceted role in AD pathogenesis through several mechanisms:
DNA Damage Accumulation
Neurons in AD brains show extensive DNA damage, including single-strand breaks, double-strand breaks, and oxidized base lesions. FEN1 expression and activity are significantly reduced in AD brains, leading to impaired LP-BER and progressive accumulation of DNA lesions 4.
Tau Pathology
FEN1 interacts with tau protein, and pathological tau (p-tau) sequesters FEN1 away from its DNA repair functions. This creates a vicious cycle where tau pathology impairs DNA repair, leading to more DNA damage, which then exacerbates tau pathology through activation of DNA damage response pathways 5.
Amyloid-β Interaction
Research has shown that amyloid-beta (Aβ) peptides can directly inhibit FEN1 activity. Aβ(1-40) and Aβ(1-42) peptides bind to FEN1 and reduce its flap endonuclease activity, providing another mechanism by which Aβ impairs neuronal DNA repair 6.
Oxidative Stress
AD brains experience chronic oxidative stress from mitochondrial dysfunction, metal accumulation, and neuroinflammation. This results in high levels of 8-oxoguanine (8-oxoG) and other oxidized bases that require FEN1-dependent LP-BER for removal. When FEN1 is compromised, oxidized bases accumulate, leading to G→T transversions and genomic instability.
FEN1 dysfunction is particularly relevant to PD due to the special vulnerability of dopaminergic neurons:
Mitochondrial DNA Repair
Dopaminergic neurons in the substantia nigra have high mitochondrial activity and are subject to continuous oxidative stress from dopamine metabolism. FEN1 is essential for repairing mitochondrial DNA (mtDNA) damage through LP-BER. Impaired mtDNA repair leads to mitochondrial dysfunction, respiratory chain defects, and neuronal death 7.
α-Synuclein Interaction
α-Synuclein, the key protein in PD pathogenesis, can directly inhibit FEN1 activity. Studies show that α-synuclein oligomers bind to FEN1 and reduce its nuclease activity, linking protein aggregation to DNA repair impairment 8.
LRRK2 Connection
Mutations in LRRK2 (leucine-rich repeat kinase 2) are a common genetic cause of PD. LRRK2 phosphorylates FEN1 at Thr607, and this phosphorylation is required for optimal FEN1 activity during DNA repair. PD-associated LRRK2 mutations alter this phosphorylation, potentially contributing to DNA repair defects 9.
Neurons are particularly susceptible to DNA damage for several reasons:
When DNA damage accumulates, neurons activate the DNA damage response (DDR), which includes:
In AD and PD, chronic DNA damage overwhelms repair capacity, leading to DDR exhaustion and neuronal death.
Given FEN1's central role in neurodegeneration, several therapeutic strategies are being explored:
1. FEN1 Activators
Small molecules that enhance FEN1 activity could improve DNA repair capacity in neurons. Examples under investigation include:
2. Gene Therapy
Viral vector delivery of FEN1 to specific brain regions could restore DNA repair capacity. However, careful dosing is required as excessive FEN1 activity could lead to genomic instability.
3. Combination Approaches
Targeting multiple DNA repair pathways simultaneously may be more effective:
FEN1 activity in cerebrospinal fluid (CSF) or blood may serve as a biomarker for neuronal DNA repair capacity:
Several FEN1 variants have been associated with increased neurodegeneration risk:
| Variant | Function | Disease Association |
|---|---|---|
| R70Q | Reduced flap activity | AD risk |
| G240D | Impaired BER | PD risk |
| D181N | Reduced activity | Werner Syndrome |
Common polymorphisms in FEN1 promoter and coding regions affect expression and activity:
Several mouse models have been developed to study FEN1 in neurodegeneration:
FEN1 Knockout
FEN1⁻/⁻ mice are embryonic lethal, demonstrating its essential role in DNA repair. FEN1⁺/⁻ mice show:
Conditional Knockout
Neuron-specific FEN1 deletion leads to:
Transgenic Overexpression
FEN1 overexpression protects against:
FEN1 intersects with multiple neurodegenerative pathways:
FEN1 mutations affecting its enzymatic activity can lead to genomic instability in neurons, which are post-mitotic cells highly vulnerable to DNA damage accumulation.
FEN1 encodes a structure-specific endonuclease that specifically recognizes and cleaves DNA flaps during DNA replication and repair. The protein removes 5' overhanging flaps in base excision repair and processes the 5' ends of Okazaki fragments during lagging strand DNA synthesis [1].
The enzymatic activity involves:
FEN1 interacts with multiple DNA repair pathways:
Neurons are post-mitotic cells that cannot divide, meaning they cannot rely on replication to dilute DNA damage. Consequently, DNA damage accumulates over time, and efficient repair mechanisms are critical for neuronal survival.
FEN1 mutations cause a variant of Werner Syndrome, a progeroid disorder characterized by accelerated aging. This connection highlights FEN1's role in maintaining genomic integrity [3].